Generic Injectables Market to Grow Due to Constant Advances in Parenteral Drug Delivery
Several top players in the Generic Injectables Market are focusing on mergers and acquisitions to consolidate their shares. They are also making substantial investment in research and development activities with an aim to develop new products, in order to gain an edge over their competitors, notes Transparency Market Research (TMR). Some of the companies holding leading positions in the market are Biocon Limited, Sanofi, Lupin Ltd., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius SE & Co. KGaA, Baxter,...
View full press release